EORTC joins Walgreens Boots Alliance in celebrating a decade of impact
EORTC – European Organisation for Research and Treatment of Cancer posted on LinkedIn:
“Live from London: we are proud to join Walgreens Boots Alliance (WBA) in celebrating a decade of impact through their ESG Report. As part of this milestone event, EORTC CEO Denis Lacombe participates in the panel discussion, Enabling Healthy Futures: Together in Partnership, to highlight how collaboration drives progress in clinical cancer research and patient care.
For over 12 years, our partnership with WBA has helped us develop innovative clinical research infrastructures, like SPECTA platform and E2-RADIatE, bringing better access to evidence-based cancer treatments for patients across Europe.
Looking ahead, we remain committed to driving progress in cancer treatment and care, ensuring no patient is left behind.
Thank you, WBA, for your continued support in shaping a healthier future, together!”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023